One of Trump’s executive orders establishes a childhood chronic disease committee that includes heads of FDA and USDA.
The $8.6 billion business – nearly 16% of the company – performed well in 2024 despite increases in cocoa and dairy costs; spinoff by the end of this year.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback